Informations générales (source: ClinicalTrials.gov)
Extracorporeal Membrane Oxygenation and Cerebral Blood Flow Velocity Evaluated by Transcranial Doppler (ECMO-DTC)
Interventional
N/A
University Hospital, Toulouse (Voir sur ClinicalTrials)
avril 2018
septembre 2020
29 juin 2024
To determine how venoarterial extracorporeal membrane oxygenation (ECMO) affects cerebral
blood flow velocity (CBFV) measured by transcranial doppler (TCD), to determine whether
specific changes in cerebral blood flow velocity may be associated with neurologic injury
and to determine modifications of CBFV after withdrawal of ECMO.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| University Hospital Toulouse - 31059 - Toulouse - France | Fanny BOUNES, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- adult patient who receiving ECMO therapy
- adult patient who receiving ECMO therapy
- cervico-encephalic vasculopathy
- lacked an acoustic window allowing for adequate TCD examination
- stroke in medical past.